ORIGENE TECHNOLOGIES, INC.

Profile

Company Names

ORIGENE TECHNOLOGIES, INC.

Addresses

9620 MEDICAL CENTER DRIVE, SUITE 200, ROCKVILLE, MD 20850

Phone Numbers

301-340-3188

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$38,629,425.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2015-05-26 
$17,051,983.00 
$32,050,000.00 
$14,998,017.00 
Equity 
3
2014-02-24 
$200,000.00 
$200,000.00 
$0.00 
Equity 
2
2013-03-07 
$6,377,442.00 
$6,377,442.00 
$0.00 
Equity 
1
2012-08-21 
$15,000,000.00 
$15,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
TOM 
 
BLUTH 
DIRECTOR
ORIGENE TECHNOLOGIES, INC.
GENE 
 
DOVE 
EXECUTIVE OFFICER
ORIGENE TECHNOLOGIES, INC.
LANCHUN 
 
DUAN 
DIRECTOR
ORIGENE TECHNOLOGIES, INC.
ANIL 
 
GUPTA 
DIRECTOR
ORIGENE TECHNOLOGIES, INC.   |  WYEBOT, INC.
RICH 
 
HAMER 
EXECUTIVE OFFICER
ORIGENE TECHNOLOGIES, INC.
WEI-WU 
 
HE 
EXECUTIVE OFFICER, DIRECTOR
ENTREMED INC   |  ORIGENE TECHNOLOGIES, INC.   |  HUMAN LONGEVITY, INC.   |  CASI PHARMACEUTICALS, INC.
JAMES 
 
HU 
EXECUTIVE OFFICER
RODOBO INTERNATIONAL INC   |  ORIGENE TECHNOLOGIES, INC.   |  HUMAN LONGEVITY, INC.
KARL 
 
KOVACS 
EXECUTIVE OFFICER
ORIGENE TECHNOLOGIES, INC.
BEATRICE 
 
LEUNG 
DIRECTOR
ORIGENE TECHNOLOGIES, INC.
ELLEN 
 
SHIH 
DIRECTOR
ORIGENE TECHNOLOGIES, INC.
YOUMIN 
 
SHU 
EXECUTIVE OFFICER
ORIGENE TECHNOLOGIES, INC.
TONY 
 
SU 
DIRECTOR
ORIGENE TECHNOLOGIES, INC.
AMY 
 
TANG 
DIRECTOR
ORIGENE TECHNOLOGIES, INC.
QUAN 
 
ZHOU 
DIRECTOR
IDG-ACCEL CHINA CAPITAL II L.P.   |  IDG-ACCEL CHINA GROWTH FUND III L.P.   |  WUPIMA INC   |  ORIGENE TECHNOLOGIES, INC.   |  JENAVALVE TECHNOLOGY INC   |  BIONANO GENOMICS, INC   |  ACCUTAR BIOTECHNOLOGY INC.   |  IDG BREYER CAPITAL FUND L.P.   |  IDG CAPITAL PROJECT FUND II, L.P.   |  TIGER BIOTHERAPEUTICS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2015-06-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-05-26 
2014-03-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-02-24 
2013-03-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-03-07 
2012-09-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-08-21 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#